Organizing Committee Office

Division of Gastroenterology,
Department of Medicine,
Kurume University
School of Medicine

67 Asahi-machi, Kurume
830-0011, JAPAN

Conference Secretariat

c/o Convention Linkage, Inc.

Daisan Hakata Kaisei Bldg.,
1-3-6, Hakata-eki-minami,
Hakata-ku, Fukuoka-shi,
Fukuoka, 812-0016, Japan
TEL: +81-92-437-4188
FAX: +81-92-437-4182
E-mail:jshilc2021@c-linkage.co.jp

Abstract submission

Important Dates (Japan Standard Time (GMT+9hr))

Online submission starts from April 5 (Mon) 2021, 9:00.
The Submission Deadline is June 16 (Wed) 2021, 12:00.

Type of Presentation

Please select “Poster Only” or “Oral or Poster”.
Oral presentations will be selected by the organizing committee.

Category

Please choose two of the following categories for your abstract submission.

  • Epidemiology
  • Pathogenesis
  • Diagnosis/surveillance
  • Loco-regional therapy (RFA/TACE/HAIC/Radiation etc.)
  • Systemic therapy (molecular targeted therapy etc.)
  • Immunotherapy
  • Surgical therapy/Liver transplantation
  • Treatment for BCLC-B
  • Prognosis
  • Prevention
  • Basic research
  • Viral Hepatitis/Fibrosis/Portal hypertension/NASH
  • Others
  • The New Talent Workshop*
    Theme: Breakthrough basic researches in HCC for newly developed molecular and immune targeted therapies

    *The candidates for this session should be 45 years old or younger on the first day of JSH International Liver Conference. (Oct. 2nd, 2021)

Award

Best Poster Award (Regardless of age)

Outstanding presentations will be awarded out of all the submitted poster presentations.
This award is open for all ages.

Instructions for online abstract submission

  • Title of abstract: 30 words maximum.
  • Abstract body (excluding title, authors, and their institutions): 400 words maximum
    Tables and graphs should not be included in the abstract.
    References can be included in the body of the text.

Abstract Correction

The abstract can be saved, edited, and revised during the submission period through the abstract submission system.

Notification of Acceptance

Notification of acceptance/rejection of abstracts will be sent to your e-mail address by the end of July 2021.

The presenting author will receive all correspondence regarding the abstract status, presentation type, date and time, via the email address registered in the abstract submission system.

Conflict of interest

Presenting authors must state any conflict of interest (COI status). The conflict of interest policy applies not only to clinical research, but also to all medical studies including bioscience research, basic medical research, and clinical trials.

If you are required to declare a COI when registering your abstract, please follow the request below.

Inquiry for Abstract Submission

Secretariat of JSH International Liver Conference 2021
TEL: +81-92-437-4188 FAX: +81-92-437-4182
E-mail:jshilc2021@c-linkage.co.jp